Case report: challenges in monitoring and treatment of anthracycline induced cardiotoxicity in young adults with osteosarcoma

Neo(adjuvant) systemic treatment regimens containing anthracyclines such as doxorubicin cause a significant risk of heart failure. These regimens are one of the corner stones of osteosarcoma treatment, and therefore several guidelines are in place to steer cardiotoxicity monitoring through baseline...

Descripción completa

Detalles Bibliográficos
Autores principales: Heemelaar, Julius C., Janson, Jeroen, Braun, Jerry, Speetjens, Frank M., van de Sande, Michiel A. J., Hugo, Juan D. V., Barge-Schaapveld, Daniela Q. C. M., Beeres, Saskia L. M. A., Tops, Laurens F., Gelderblom, Hans, Antoni, M. Louisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664690/
https://www.ncbi.nlm.nih.gov/pubmed/36380359
http://dx.doi.org/10.1186/s40959-022-00145-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664690/
https://www.ncbi.nlm.nih.gov/pubmed/36380359
http://dx.doi.org/10.1186/s40959-022-00145-y

Ejemplares similares